Over accumulation of cholesterol in cells is avoided b-Carotene and lycopene are derived from plants, by maintaining a balance between these external and and they share similar initial synthetic pathway with internal cholesterol sources. This balance is achieved cholesterol, which is synthesized in animal but not in through feedback regulation on the biosynthetic plant cells. Thus, we sought to analyze the effect of pathway, and also on the LDL receptor synthesis. respectively. However, unlike LDL derived choles-scription (4). On the other hand, cellular cholesterol terol, which also suppresses macrophage LDL recep-synthesis can also be inhibited by synthetic comtor activity, lycopene and b-carotene augmented the pounds such as the statins, which competitively activity of the macrophage LDL receptor, similarly to inhibit the enzyme HMGCoA reductase. HMGCoA rethe effect of fluvastatin. In agreement with these in ductase inhibition by simvastatin was shown to trigvitro observations, dietary supplementation of toma-ger a coordinate regulation of the expression of the to's lycopene (60mg/day) to 6 males for a 3 months pe-genes coding for the reductase and for the LDL recepriod resulted in a significant 14% reduction in their tor (5). In response to statins, the activity of the celluplasma LDL cholesterol concentrations. We thus con-lar LDL receptor is markedly increased in order to clude that dietary supplementation of carotenoids meet the cellular needs for cholesterol, resulting in may act as moderate hypocholesterolemic agents, sec-an increased uptake of serum lipoprotein (6). Mevaloondary to their inhibitory effect on macrophage 3-hy-nate is the precursor of a complex series of isoprendroxy-3-methyl glutaryl coenzyme A (HMGCoA) reducoids which are processed in animal cells not only into tase, the rate limiting enzyme in cholesterol synthesis.
that excess of any end product in the mevalonate pathway could regulate the production of other prod- 
Lipoproteins. Human LDL was separated from venous blood

RESULTS
drawn into 1mg/ml of disodium EDTA, by discontinuous density gradient ultracentrifugation at dÅ1.019-1.063 g/ml (10) . LDL was radioiodinated by the iodine monochloride method as modified for lipoproUpon incubation of J-774 A.1 macrophages with in- ids were extracted in hexane: isopropanol (3:2, v:v), separated by dependent manner, reaching a maximum inhibition of thin layer chromatography (TLC) on silica gel plates, and developed 88% and 98% on using 60mg of LDL cholesterol/ml, or in hexane:ether: acetic acid (80:20:1.5, v:v:v). Unesterified cholesterol 1mg of fluvastatin/ml, respectively (Fig 1) . Similarly, spots were visualized by iodine vapour (using appropriate standard)
supplementation of the cells with increasing concentrascraped into scintillation vials and counted in a b-counter.
tions of b-carotene or lycopene resulted in a dose-de- ited by 73% or by 63%, respectively (Fig 1) . Both choles- of 3 months. This treatment resulted in a significant terol and fluvastatin inhibit cellular cholesterol synthe-(põ0.02) 14% reduction in plasma LDL-cholesterol consis as a result of their inhibitory effect on the enzyme centration (from 165{10 mg/dl before lycopene suppleHMGCoA reductase, though by different mechanisms. mentation to 140{11 mg/dl after 3 months of lycopene In order to examine whether b-carotene or lycopene consumption), with no effect on HDL-cholesterol conalso affect cholesterol synthesis along this pathway centrations (data not shown). from acetyl CoA to mevalonate, we tested the ability of the carotenoids to inhibit cholesterol synthesis from DISCUSSION The present study demonstrates that b-carotene, and that suppressed [ 3 H]acetate incorporation into cellular its precursor lycopene, suppress cellular cholesterol cholesterol by Ç40% did not result in any significant inhibition in cholesterol synthesis from the radiolabeled mevalonate (Fig 2) . These data strongly suggest that b-carotene and lycopene regulate macrophage cholesterol synthesis by inhibiting cellular HMGCoA reductase activity. Inhibition of cholesterol synthesis by cellular cholesterol loading inhibits LDL receptor activity, whereas statins, which also inhibit cholesterol synthesis (by a different mechanism), stimulate the LDL receptor activity. We thus studied the effect of cells enrichment with carotenoids on macrophage LDL receptor activity, in comparison to the effects of LDLcholesterol or statins. Fig 3 demonstrates that on using 10mM of carotenoids, macrophage enrichment with bcarotene or with lycopene resulted in 25% or 34% increased cellular LDL degradation (Fig 3A) , and in 36% or 109% increased cell-association of LDL (Fig 3B) , similarly to the effect of fluvastatin (1mg/ml) and in contrast to the inhibitory effect of 50mg of LDL cholesterol/ ml (Fig 3) . These results suggest that cell enrichment with carotenoids can increase the removal of LDL from 60mg of lycopene/day to 6 healthy males for a period
